In_FW
vivo_FW
footprinting_NN
and_CC
mutational_JJ
analysis_NN
of_IN
the_DT
proximal_JJ
CD19_NN
promoter_NN
reveal_VBP
important_JJ
roles_NNS
for_IN
an_DT
SP1\/Egr_NN
-1_CD
binding_NN
site_NN
and_CC
a_DT
novel_JJ
site_NN
termed_VBN
the_DT
PyG_NN
box_NN
._.

CD19_NN
expression_NN
begins_VBZ
at_IN
the_DT
pro-B_JJ
cell_NN
stage_NN
of_IN
B_NN
cell_NN
development_NN
._.

As_IN
such_JJ
it_PRP
serves_VBZ
as_IN
a_DT
good_JJ
prototype_NN
for_IN
B_NN
cell-specific_JJ
genes_NNS
whose_WP$
expression_NN
begins_VBZ
shortly_RB
after_IN
lineage_NN
commitment_NN
._.

To_TO
understand_VB
the_DT
molecular_JJ
mechanisms_NNS
controlling_VBG
CD19_NN
gene_NN
expression_NN
,_,
we_PRP
isolated_VBD
and_CC
functionally_RB
characterized_VBD
the_DT
CD19_NN
promoter_NN
using_VBG
in_FW
vivo_FW
footprinting_NN
,_,
gel_NN
shift_NN
assays_NNS
,_,
and_CC
transfection_NN
studies_NNS
._.

Reporter_NN
constructs_NNS
spanning_VBG
portions_NNS
of_IN
the_DT
promoter_NN
identified_VBD
a_DT
region_NN
between_IN
-85_CD
and_CC
-200_CD
that_WDT
produced_VBD
high_JJ
levels_NNS
of_IN
reporter_NN
gene_NN
activity_NN
in_IN
lymphoid_JJ
cells_NNS
._.

In_FW
vivo_FW
footprinting_NN
identified_VBD
protected_JJ
regions_NNS
over_IN
the_DT
known_JJ
high_JJ
affinity_NN
B_NN
cell_NN
lineage-specific_JJ
activator_NN
protein_NN
-LRB-_-LRB-
BSAP_NN
-RRB-_-RRB-
site_NN
,_,
the_DT
low_JJ
affinity_NN
BSAP_NN
site_NN
,_,
a_DT
SP1\/Egr_NN
-1_CD
site_NN
termed_VBN
the_DT
CD19_NN
GC_NN
box_NN
,_,
and_CC
two_CD
novel_JJ
sites_NNS
named_VBN
the_DT
AT_NN
box_NN
and_CC
PyG_NN
box_NN
._.

Phorbol_NN
ester_NN
treatment_NN
of_IN
a_DT
pre-B_JJ
cell_NN
line_NN
up-regulated_VBD
CD19_NN
expression_NN
,_,
induced_VBD
Egr-1_NN
,_,
and_CC
enhanced_VBD
the_DT
footprint_NN
over_IN
the_DT
GC_NN
box_NN
._.

Gel_NN
shift_NN
assays_NNS
demonstrated_VBD
SP1_NN
and_CC
Egr-1_NN
binding_NN
to_TO
the_DT
CD19_NN
GC_NN
box_NN
,_,
while_IN
unknown_JJ
nuclear_JJ
proteins_NNS
bound_VBD
the_DT
PyG_NN
and_CC
AT_NN
boxes_NNS
._.

Mutations_NNS
in_IN
the_DT
AT_NN
box_NN
or_CC
in_IN
the_DT
BSAP_NN
sites_NNS
did_VBD
not_RB
affect_VB
CD19_NN
reporter_NN
construct_NN
activity_NN
,_,
while_IN
a_DT
mutation_NN
of_IN
the_DT
GC_NN
box_NN
reduced_VBD
it_PRP
modestly_RB
,_,
and_CC
a_DT
PyG_NN
box_NN
mutation_NN
reduced_VBD
it_PRP
dramatically_RB
._.

BSAP_NN
failed_VBD
to_TO
trans-activate_VB
CD19_NN
promoter_NN
constructs_NNS
in_IN
B_NN
cells_NNS
or_CC
non-B_JJ
cells_NNS
,_,
suggesting_VBG
that_IN
cis_JJ
elements_NNS
such_JJ
as_IN
the_DT
PyG_NN
and_CC
GC_NN
boxes_NNS
are_VBP
also_RB
necessary_JJ
for_IN
high_JJ
level_NN
CD19_NN
promoter_NN
expression_NN
._.

